Average Co-Inventor Count = 4.39
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (134 from 2,285 patents)
2. Exonhit Therapeutics, Sa (12 from 25 patents)
3. Allergan Sales, Inc. (1 from 228 patents)
4. Allegran, Inc. (1 from 1 patent)
136 patents:
1. 11331306 - Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
2. 11208377 - 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof
3. 11046644 - Sulfur derivatives as chemokine receptor modulators
4. 10993931 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
5. 10899780 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
6. 10799518 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
7. 10555933 - Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
8. 10434112 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
9. 10287243 - Sulfur derivatives as chemokine receptor modulators
10. 10251865 - Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
11. 10208071 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
12. 10201535 - Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
13. 10172832 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
14. 10123988 - Compositions including encapsulated isotretinoin and methods for use thereof
15. 9974772 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators